DASATINIB
Active substance: dasatinib
TABLET · DASATINIB 50 mg/1
United StatesActive
Marketing holder: Aurobindo Pharma Limited
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- DASATINIB · 50 mg/1
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 24 |
|
| EU 4 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-3207-779a-8ea0-ccf9b5a4a206,01a120c3-4abe-7a6e-91c1-950626fe1c5c,01a120c3-5b35-73b3-9420-14989ac6e862,01a120c3-5cb7-70bd-82f0-afc6f5ba4b73,01a120c3-5cbe-700b-a396-c2a31f031397;count=21 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2969-701b-be90-3e61f20b5595,01a1208c-2aff-749d-bdff-0e04944b3655,01a1208c-2b00-7052-b1fc-c9e3d59b3e33,01a1208c-2cda-7588-b22b-b448542afae5,01a1208c-2eac-7ba1-a683-fec138fdaf53;count=102 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 59651-543
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
- product · openFDA NDC · 59651-543 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 59651-543 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 59651-543 · Verified 2026-10-09 · open in source